Gail Brown

Brown with [[William Russ]] on ''Another World'', 1977. Gail Marjorie Brown (née Ziegler; born October 11, 1937) is an American former actress. She is best known for her role as Clarice Hobson on the NBC daytime soap opera ''Another World'' (1975–1986). Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Brown, Gail', query time: 0.03s Refine Results
  1. 1
    Quantum sensing and nanophotonic devices X : 3-7 February 2013, San Francisco, California, United States /

    Quantum sensing and nanophotonic devices X : 3-7 February 2013, San Francisco, California, United States / by Razeghi, Manijeh, Tourni,̌ Eric, Brown, Gail J. 524146

    Published 2013
    text
  2. 2
    Quantum sensing and nanophotonic devices VIII : 23-27 January 2011, San Francisco, California, United States /

    Quantum sensing and nanophotonic devices VIII : 23-27 January 2011, San Francisco, California, United States / by Sudharsanan, Rengarajan, Brown, Gail J., Razeghi, M., SPIE (Society)

    Published c201
  3. 3
    Oral ezatiostat HCl (Telintra<sup>®</sup>, TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following treatment with ezatiostat, a glutathione S-transferase P1-1 (GSTP1-1) inhibitor

    Oral ezatiostat HCl (Telintra<sup>®</sup>, TLK199) and Idiopathic Chronic Neutropenia (ICN): a case report of complete response of a patient with G-CSF resistant ICN following trea... by Lyons Roger M, Wilks Sharon T, Young Shelby, Brown Gail L

    Published 2011-11-01
    Get full text
    Article
  4. 4
    Quantum sensing and nanophotonic devices VII : 24-28 January 2010, San Francisco, California, United States /

    Quantum sensing and nanophotonic devices VII : 24-28 January 2010, San Francisco, California, United States / by Razeghi, M. 524143, Sudharsanan, Rengarajan 524144, Brown, Gail J. 524146, SPIE (Society) 8756

    Published 2010
    text
  5. 5
    Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome

    Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome by Galili, Naomi, Tamayo, Pablo, Brooks, Margarita R., Brown, Gail, Raza, Azra, Mesirov, Jill P., Botvinnik, Olga B., Brooks, Margarita R.

    Published 2012
    Get full text
    Article
  6. 6
    Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer

    Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer by Moore Carla L, Wolf Judith L, Ramirez Pedro T, Levenback Charles F, Kavanagh John J, Jones Marsha R, Meng Lisa, Brown Gail L, Bast Robert C

    Published 2010-03-01
    Get full text
    Article
  7. 7
    Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra<sup>®</sup>, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

    Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra<sup>®</sup>, TLK199), a novel glutathione analog prodrug in patients with... by Burris Howard, Williams Stephanie, Emanuel Peter, Piro Lawrence, Ochoa Leonel, Callander Natalie, Galili Naomi, Raza Azra, Faderl Stefan, Estrov Zeev, Curtin Peter, Larson Richard A, Keck James G, Jones Marsha, Meng Lisa, Brown Gail L

    Published 2009-05-01
    Get full text
    Article

Search Tools: